3
Views
4
CrossRef citations to date
0
Altmetric
Special Report

p38 MAPK inhibitors in dermatology

Pages 403-407 | Published online: 10 Jan 2014
 

Abstract

p38 mitogen-activated protein kinase (MAPK) is involved in regulating cell growth, cell differentiation, cell proliferation, cell apoptosis and response to inflammation and stress. Four mammalian p38 MAPK isoforms, p38 MAPKα, p38 MAPKβ, p38 MAPKγ (ERK6/SAPK3) and p38 MAPKδ (SAPK4), have been identified. Specific inhibitors of p38 MAPK, pyridinyl imidazole compounds, such as SB203580 and SB202190, are known. In this special report, the role of p38 MAPK and its specific inhibitors in the skin are discussed.

Financial disclosure

The author has no relevant financial interests, including employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties related to this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.